Aptamers specific for biomolecules and methods of making
AssigneeGilead Sciences, Inc.
InventorsLinda Griffin, Glenn Albrecht, John Latham, Lawrence Leung, Eric Vermaas, John J. Toole
Life of this patent
Estimating the term…
Loading patent…
AssigneeGilead Sciences, Inc.
InventorsLinda Griffin, Glenn Albrecht, John Latham, Lawrence Leung, Eric Vermaas, John J. Toole
Estimating the term…
A method for identifying oligomer sequences, optionally comprising modified base, which specifically bind target molecules such as serum proteins, kinins, eicosanoids and extracellular proteins is described. The method is used to generate aptamers that bind to serum Factor X, PDGF, FGF, ICAM, VCAM, E-selectin, thrombin, bradykinin, PGF2 and cell surface molecules. The technique involves complexation of the target molecule with a mixture of oligonucleotides containing random sequences and sequences which serve as primer for PCR under conditions wherein a complex is formed with the specifically binding sequences, but not with the other members of the oligonucleotide mixture. The complex is then separated from uncomplexed oligonucleotides and the complexed members of the oligonucleotide mixture are recovered from the separated complex using the polymerase chain reaction. The recovered oligonucleotides may be sequenced, and successive rounds of selection using complexation, separation, amplification and recovery can be employed. The oligonucleotides can be used for therapeutic and diagnostic purposes and for generating secondary aptamers.
A method to detect the presence or absence of thrombin, which method comprises:
A method to purify thrombin, which method comprises:
Dependencies are inferred from the claim text.